ARTICLE | Clinical News
ReoPro abciximab: Phase II data; marketed
November 19, 2001 8:00 AM UTC
Centocor partner Eli Lilly and Co. (LLY, Indianopolis, Ind.) said 6-month analysis of a predefined subset of 53 patients with diabetes undergoing angioplasty during acute MI from the ADMIRAL Phase II...